文献速递妇产影像US

大脑中动脉速度时间积分预测胎儿血红蛋白巴特病胎儿贫血

Middle cerebral artery velocity time integral as a predictor of fetal anemia using fetal hemoglobin Bart's disease as study model.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-03-27

本研究为前瞻性数据的二次分析,纳入2008年1月至2023年12月在泰国清迈医院母胎医学中心就诊的485例孕17-22周有胎儿血红蛋白巴特病风险的孕妇,评估大脑中动脉速度时间积分(MCA-VTI)预测胎儿血红蛋白巴特病的诊断效能。结果显示,受累胎儿MCA-VTI绝对值及中位数倍数(MoM)均显著高于未受累胎儿,且MCA-VTI的诊断效能优于MCA-PSV。结论提示MCA-VTI可作为MCA-PSV的替代或补充指标用于检测胎儿贫血,尤其在血红蛋白巴特病中可能适用。

要点

  • 受累胎儿MCA-VTI绝对值7.9±1.8 vs 未受累5.4±1.3(P<0.001),MoM值1.5±0.3 vs 1.0±0.2(P<0.001)。
  • MCA-VTI预测Hb Bart's病的AUC:绝对值0.877(95%CI 0.836-0.917),MoM 0.898(95%CI 0.857-0.938)。
  • MCA-VTI诊断效能优于MCA-PSV(绝对值AUC 0.842,95%CI 0.795-0.889;MoM AUC 0.854,95%CI 0.809-0.899),P<0.001。

核心结论

  • MCA-VTI预测胎儿血红蛋白巴特病(间接反映贫血)的准确性优于MCA-PSV,提示MCA-VTI可作为MCA-PSV的替代或补充用于检测胎儿贫血,尤其在血红蛋白巴特病中可能适用,并可能适用于其他病因。

研究设计与样本

  • 前瞻性收集数据的二次分析,纳入2008年1月至2023年12月泰国清迈医院母胎医学中心孕17-22周有胎儿血红蛋白巴特病风险的孕妇,共485例胎儿(受累109例,未受累376例),以脐带穿刺血血红蛋白分型为最终诊断参考标准。

诊断标准与关键数值

  • 受累胎儿MCA-VTI绝对值7.9±1.8 vs 未受累5.4±1.3(P<0.001),MoM值1.5±0.3 vs 1.0±0.2(P<0.001);MCA-VTI绝对值(cm)AUC 0.877(95%CI 0.836-0.917),MoM AUC 0.898(95%CI 0.857-0.938);MCA-PSV绝对值(cm/s)AUC 0.842(95%CI 0.795-0.889),MoM AUC 0.854(95%CI 0.809-0.899);MCA-VTI与MCA-PSV的AUC比较P<0.001。

临床应用与阅片要点

  • 作者认为MCA-VTI可作为MCA-PSV的替代或补充用于检测胎儿贫血,尤其在血红蛋白巴特病中可能适用,并可能适用于其他病因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the diagnostic performance of middle cerebral artery (MCA) velocity time integral (VTI) in predicting fetal hemoglobin (Hb) Bart's disease.

METHODS: This was a secondary analysis of data collected prospectively from pregnant women at risk for fetal Hb Bart's disease assessed at 17-22 weeks' gestation, receiving care at the Maternal-Fetal Medicine Unit, Chiang Mai Hospital, Thailand, between January 2008 and December 2023. Each fetus underwent prenatal measurement of MCA peak systolic velocity (PSV) and MCA-VTI. Final diagnosis of Hb Bart's disease was confirmed by Hb typing of cord blood, obtained by cordocentesis. MCA-PSV and MCA-VTI were evaluated both as absolute values and multiples of median (MoM) normalized for gestational age. Diagnostic performance of MCA-PSV and MCA-VTI for predicting fetal Hb Bart's disease was evaluated and compared using area under the receiver-operating-characteristics curve (AUC), sensitivity, specificity and positive and negative predictive values.

RESULTS: A total of 485 fetuses at risk for Hb Bart's disease (109 affected, 376 unaffected) met the inclusion criteria. Absolute MCA-VTI values were significantly higher in affected compared with unaffected fetuses (7.9 ± 1.8 vs 5.4 ± 1.3; P < 0.001) as were MoM values (1.5 ± 0.3 vs 1.0 ± 0.2; P < 0.001). The diagnostic performance of MCA-VTI was superior to that of MCA-PSV for detecting fetal anemia due to Hb Bart's disease, with AUCs of 0.877 (95% CI, 0.836-0.917) and 0.898 (95% CI, 0.857-0.938) for absolute MCA-VTI values (in cm) and MCA-VTI MoM, respectively, compared with 0.842 (95% CI, 0.795-0.889) and 0.854 (95% CI, 0.809-0.899) for absolute MCA-PSV values (in cm/s) and MCA-PSV MoM, respectively (P < 0.001).

CONCLUSION: MCA-VTI is more accurate compared with MCA-PSV for predicting fetal Hb Bart's disease, which indirectly reflects anemia. This suggests that MCA-VTI could serve as an alternative or adjunct to MCA-PSV for detecting fetal anemia, particularly in cases of Hb Bart's disease and potentially for other etiologies. © 2025 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Parapob N, Jatavan P, Luewan S, et al. Middle cerebral artery velocity time integral as a predictor of fetal anemia using fetal hemoglobin Bart's disease as study model. Ultrasound Obstet Gynecol. 2025. PMID: 40150971. doi:10.1002/uog.29213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。